{"title":"木犀叶茎叶化学成分的研究","authors":"Xiaowei Zhao , Chunhui Yu , Caixia Guo , Haojing Jiang , Hai-Jiang Zhang , Yuanqiang Guo , Jing Xu","doi":"10.1016/j.phytol.2025.103023","DOIUrl":null,"url":null,"abstract":"<div><div>The ongoing importance of natural products in drug discovery is highlighted by our investigation. We report the isolation of a novel carbazole alkaloid (<strong>1</strong>) and 18 known compounds (<strong>2</strong>−<strong>19</strong>) from <em>Murraya euchrestifolia</em> to identify potential anti-tumor agents. The structures of these compounds were elucidated through various spectroscopic analysis including NMR, MS, electronic circular dichroism (ECD), and NMR calculations. The isolated compounds were subsequently evaluated for their affinity towards the vascular endothelial growth factor receptor-2 (VEGFR-2) through affinity screening. Molecular docking simulations, employing a hybrid Lamarckian Genetic Algorithm (LGA) to select conformations with binding energies ranging from −6.9 to −10.1 kcal/mol, revealed that compounds <strong>1</strong>, <strong>6</strong>, <strong>8</strong>, <strong>10</strong>−<strong>14</strong>, <strong>16</strong>, and <strong>19</strong> exhibited significant affinity for the VEGFR-2 protein. Furthermore, compounds <strong>1</strong>, <strong>6</strong>, <strong>8</strong>, <strong>13</strong>, and <strong>19</strong> demonstrated multiple binding sites with VEGFR-2, while compound <strong>10</strong> displayed the lowest binding energy (−10.1 kcal/mol). These findings provided a solid foundation for further investigation into the anti-tumor mechanisms of these compounds.</div></div>","PeriodicalId":20408,"journal":{"name":"Phytochemistry Letters","volume":"69 ","pages":"Article 103023"},"PeriodicalIF":1.4000,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Studies on the chemical constituents of the stems and leaves of Murraya euchrestifolia\",\"authors\":\"Xiaowei Zhao , Chunhui Yu , Caixia Guo , Haojing Jiang , Hai-Jiang Zhang , Yuanqiang Guo , Jing Xu\",\"doi\":\"10.1016/j.phytol.2025.103023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The ongoing importance of natural products in drug discovery is highlighted by our investigation. We report the isolation of a novel carbazole alkaloid (<strong>1</strong>) and 18 known compounds (<strong>2</strong>−<strong>19</strong>) from <em>Murraya euchrestifolia</em> to identify potential anti-tumor agents. The structures of these compounds were elucidated through various spectroscopic analysis including NMR, MS, electronic circular dichroism (ECD), and NMR calculations. The isolated compounds were subsequently evaluated for their affinity towards the vascular endothelial growth factor receptor-2 (VEGFR-2) through affinity screening. Molecular docking simulations, employing a hybrid Lamarckian Genetic Algorithm (LGA) to select conformations with binding energies ranging from −6.9 to −10.1 kcal/mol, revealed that compounds <strong>1</strong>, <strong>6</strong>, <strong>8</strong>, <strong>10</strong>−<strong>14</strong>, <strong>16</strong>, and <strong>19</strong> exhibited significant affinity for the VEGFR-2 protein. Furthermore, compounds <strong>1</strong>, <strong>6</strong>, <strong>8</strong>, <strong>13</strong>, and <strong>19</strong> demonstrated multiple binding sites with VEGFR-2, while compound <strong>10</strong> displayed the lowest binding energy (−10.1 kcal/mol). These findings provided a solid foundation for further investigation into the anti-tumor mechanisms of these compounds.</div></div>\",\"PeriodicalId\":20408,\"journal\":{\"name\":\"Phytochemistry Letters\",\"volume\":\"69 \",\"pages\":\"Article 103023\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-08-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Phytochemistry Letters\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1874390025011139\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytochemistry Letters","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1874390025011139","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Studies on the chemical constituents of the stems and leaves of Murraya euchrestifolia
The ongoing importance of natural products in drug discovery is highlighted by our investigation. We report the isolation of a novel carbazole alkaloid (1) and 18 known compounds (2−19) from Murraya euchrestifolia to identify potential anti-tumor agents. The structures of these compounds were elucidated through various spectroscopic analysis including NMR, MS, electronic circular dichroism (ECD), and NMR calculations. The isolated compounds were subsequently evaluated for their affinity towards the vascular endothelial growth factor receptor-2 (VEGFR-2) through affinity screening. Molecular docking simulations, employing a hybrid Lamarckian Genetic Algorithm (LGA) to select conformations with binding energies ranging from −6.9 to −10.1 kcal/mol, revealed that compounds 1, 6, 8, 10−14, 16, and 19 exhibited significant affinity for the VEGFR-2 protein. Furthermore, compounds 1, 6, 8, 13, and 19 demonstrated multiple binding sites with VEGFR-2, while compound 10 displayed the lowest binding energy (−10.1 kcal/mol). These findings provided a solid foundation for further investigation into the anti-tumor mechanisms of these compounds.
期刊介绍:
Phytochemistry Letters invites rapid communications on all aspects of natural product research including:
• Structural elucidation of natural products
• Analytical evaluation of herbal medicines
• Clinical efficacy, safety and pharmacovigilance of herbal medicines
• Natural product biosynthesis
• Natural product synthesis and chemical modification
• Natural product metabolism
• Chemical ecology
• Biotechnology
• Bioassay-guided isolation
• Pharmacognosy
• Pharmacology of natural products
• Metabolomics
• Ethnobotany and traditional usage
• Genetics of natural products
Manuscripts that detail the isolation of just one new compound are not substantial enough to be sent out of review and are out of scope. Furthermore, where pharmacology has been performed on one new compound to increase the amount of novel data, the pharmacology must be substantial and/or related to the medicinal use of the producing organism.